Thomas Wilson, PhD, DrPH

home / authors / thomas-wilson-phd-drph

Articles

Site Logo
November 8th 2018

Impact of Dementia on Costs of Modifiable Comorbid Conditions

Patricia R. Salber, MD, MBA Christobel E. Selecky, MA Dirk Soenksen, MS, MBA Thomas Wilson, PhD, DrPH

Alzheimer disease and other dementias (ADOD) have a substantial impact on the prevalence and costs of certain comorbid conditions compared with matched beneficiaries without ADOD.

Site Logo
June 1st 2005

Correspondence regarding, "Using a Claims Data-based Sentinel System to Improve Compliance with Clinical Guidelines: Results of a Randomized Prospective Study"

Thomas Wilson, PhD, DrPH Ariel Linden, DrPH, MS Author reply by Jonathan C. Javitt, MD, MPH

Site Logo
March 1st 2005

Correspondence regarding, "Asthma Disease Management: Regression to the Mean or Better?"

Jeffrey Levin-Scherz, MD, MBA Thomas Wilson, PhD, DrPH Ariel Linden, DrPH, MS Author reply by Scott M. Wilson, MA and David Tinkelman, MD

Latest Updated Articles

Opdivo packaging | Image credit: Bristol Myers Squibb
Published: May 9th 2024 | Updated: May 21st 2024
FDA Accepts Nivolumab Subcutaneous Injection Application, With Potential to Boost Access to PD-1 Inhibitors
Jason Porter, MD, an expert on lung cancer
Published: July 24th 2024 | Updated: July 27th 2024
Long-Term Follow-Up from CheckMate 9LA at ASCO 2024
Jason Porter, MD, an expert on lung cancer
Published: July 24th 2024 | Updated: July 27th 2024
Insights from the TROPION-Lung05 Trial at ASCO 2024
Liz Kwo, MD, MBA, MPH, chief commercial officer, Everly Health, and faculty lecturer, Harvard Medical School
Published: July 24th 2024 | Updated: July 27th 2024
Examining Trends, Future Directions in AI and Health Care
Aspirin tablets dissolving in water | Imaged credit: Victor Moussa - stock.adobe.com
Published: July 15th 2024 | Updated: July 27th 2024
No Sex Differences Identified in Aspirin Dosing for Secondary Prevention of ASCVD
Alfred L. Garfall, MD, an expert on multiple myeloma
Published: July 24th 2024 | Updated: July 27th 2024
Future Directions in the Management of Multiple Myeloma

2 Commerce Drive
Suite 100
Cranbury, NJ 08512

© 2024 MJH Life Sciences® and AJMC®.
All rights reserved.

About
Contact
Editorial Boards
Advertise
Do Not Sell My Information
Terms & Conditions
Privacy Policy
CH LogoCenter for Biosimilars Logo